- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07950423
Demonstrating Feasibility of Using a Robot to Deliver a Multicomponent Intervention to Reduce Delirium Occurrence in Hospitalized Elderly Subjects at Risk of Delirium (temidelirium)
This is a feasibility study. 20 non-ICU hospitalized patients at high risk of getting delirium will be consented and screened to receive a personalized multicomponent non-pharmacological intervention through an autonomous navigating robot at the bedside.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- The Miriam Hospital
-
Contact:
- Mriganka Singh, M.D.
- Phone Number: 401-444-5248
- Email: mriganka_singh@brown.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria: High risk of delirium: Agr >80, dementia, High readmission risk score as calculated by EPIC, postoperative
Exclusion Criteria: Patients who screen positive for delirium by CAM Patients who are actively dying Patients who cannot perform the CAM due to language or advanced dementia or level of consciousness
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: patients at high risk of delirium who meet the inclusion criteria
Feasibility study of using an autonomous mobile robot to deliver a personalized multicomponent non-pharmacological intervention to prevent delirium at the bedside |
personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Robot correctly arrived at the bedside and greeted the patient
Time Frame: Two months of feasibility study
|
The robot has to navigate to the bedside of each patient at a scheduled time |
Two months of feasibility study
|
|
Robot correctly arrived at the bedside, oriented the patient and delivered the personalized multicomponent non-pharmacological intervention.
Time Frame: Two months of the feasibility study
|
The robot has to identify the patient, get permission to talk to the patient and then deliver the orientation and engage the patient in a series of activities if the patient agrees. |
Two months of the feasibility study
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BUH3-2399997
- 1R43AG094367-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.